|
Summary
Apr 2006, Vol. 7, No. 3, Pages 387-394
, DOI 10.2217/14622416.7.3.387
(doi:10.2217/14622416.7.3.387)
Collaborative Study: chronic fatigue syndrome – Research Report Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue Alicia K Smith 1, Peter D White 2, Eric Aslakson 1, Ute Vollmer-Conna 3 & Mangalathu S Rajeevan 1†1Centers for Disease Control and Prevention, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, 1600 Clifton Road, MSG41, Atlanta, GA 30333, USA. mor4@cdc.gov 2University of London, Department of Psychological Medicine, Barts, London and Queen Mary School of Medicine and Dentistry, London, UK 3University of New South Wales, School of Psychiatry, Sydney, Australia † Author for correspondence Chronic fatigue syndrome (CFS) is characterized by persistent or relapsing fatigue that is not alleviated by rest, causes substantial reduction in activities and is accompanied by a variety of symptoms. Its unknown etiology may reflect that CFS is heterogeneous. Latent class analyses of symptoms and physiological systems were used to delineate subgroups within a population-based sample of fatigued and nonfatigued subjects [1]. This study examined whether genetic differences underlie the individual subgroups of the latent class solution. Polymorphisms in 11 candidate genes related to both hypothalamic–pituitary–adrenal (HPA) axis function and mood-related neurotransmitter systems were evaluated by comparing each of the five ill classes (Class 1, n = 33; Class 3, n = 22; Class 4, n = 22; Class 5, n = 17; Class 6, n = 11) of fatigued subjects with subjects defined as well (Class 2, n = 35). Of the five classes of subjects with unexplained fatigue, three classes were distinguished by gene polymorphsims involved in either HPA axis function or neurotransmitter systems, including proopiomelanocortin (POMC), nuclear receptor subfamily 3, group C, member 1 (NR3C1), monoamine oxidase A (MAOA), monoamine oxidase B (MAOB), and tryptophan hydroxylase 2 (TPH2). These data support the hypothesis that medically unexplained chronic fatigue is heterogeneous and presents preliminary evidence of the genetic mechanisms underlying some of the putative conditions.
Cited byLise Solberg Nes, Abbey R. Roach, Suzanne C. Segerstrom. (2009) Executive Functions, Self-Regulation, and Chronic Pain: A Review. Annals of Behavioral Medicine 37:2, 173-183 Online publication date: 1-May-2009. CrossRef Eugene Lin, Sen-Yen Hsu. (2009) A Bayesian approach to gene–gene and gene–environment interactions in chronic fatigue syndrome. Pharmacogenomics 10:1, 35-42 Online publication date: 1-Jan-2009. Summary
| Full Text
| PDF (438 KB)
| PDF Plus (479 KB) Guo-Lin Chen, Eric J. Vallender, Gregory M. Miller. (2008) Functional characterization of the human TPH2 5′ regulatory region: untranslated region and polymorphisms modulate gene expression in vitro. Human Genetics 122:6, 645-657 Online publication date: 1-Feb-2008. CrossRef Vegard Bruun Wyller. (2007) The chronic fatigue syndrome ? an update. Acta Neurologica Scandinavica 115:s187, 7 CrossRef Ellen Schur, Niloofar Afari, Jack Goldberg, Dedra Buchwald, Patrick F Sullivan. (2007) Twin Analyses of Fatigue. Twin Research and Human Genetics 10:5, 729 CrossRef
|
|
|